(Q51695717)

English

Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.

scientific article published in July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Mycobacterium tuberculosis

0 references

author name string

Juan Xu

1

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Wenhuan Xu

2

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Xia Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Dan Zhao

4

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Yingwei Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

language of work or name

0 references

publication date

1 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

26

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

35

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

4519-4525

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Comparative genomics of BCG vaccines by whole-genome DNA microarray

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Diagnosis of Mycobacterium tuberculosis infection using ESAT-6 and intracellular cytokine cytometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Modulating the immune response with dendritic cells and their growth factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Flt3 ligand (FL) and its influence on immune reactivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Enhancement of dendritic cell production by fms-like tyrosine kinase-3 ligand increases the resistance of mice to a burn wound infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

TB vaccines: progress and problems.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Dendritic cells as vectors for therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guèrin) in protecting against systemic Mycobacterim avium infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Inhibition of natural type I IFN-producing and dendritic cell development by a small molecule receptor tyrosine kinase inhibitor with Flt3 affinity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

The prime-boost strategy: exciting prospects for improved vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Prime-boost strategies for malaria vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Increased dendritic cell numbers impair protective immunity to intracellular bacteria despite augmenting antigen-specific CD8+ T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.044

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.06.044

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18598729

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51695717&oldid=1368945434"